These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6461574)

  • 1. [Efficacy of staphylococcal bacteriophage in the treatment of purulent lung and pleural diseases].
    Meladze GD; Mebuke MG; Chkhetiia NSh; Kiknadze NIa; Koguashvili GG
    Grudn Khir; 1982; (1):53-6. PubMed ID: 6461574
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with bacteriophage therapy in nonspecific suppurative lung diseases].
    Timoshchuk II; Natsiashvili EIa; Chanishvili TG; Meladze GD
    Grudn Khir; 1985; (2):11-3. PubMed ID: 3157630
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of hemosorption on immunological reactivity indices in the combined treatment of patients with extensive nonspecific destructive suppurative processes in the lungs and pleura].
    Lukomskiĭ GI; Belokrinitskiĭ DV; Saakian NA; Shelepin AA; Kudriavitskiĭ AI
    Grudn Khir; 1985; (2):20-3. PubMed ID: 3988106
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience in the work of a phthisiosurgical department in treating patients with nontuberculosis diseases].
    Ponomarenko AA; Morozov AF; Katrutsa VA
    Vrach Delo; 1972 May; 5():146-8. PubMed ID: 5029786
    [No Abstract]   [Full Text] [Related]  

  • 5. [Epidemiology and treatment of suppurative lung and pleural diseases in a children's hospital from 1936-1966 (399 cases)].
    Krepler P
    Arch Kinderheilkd; 1968; 178(1):29-53. PubMed ID: 5718973
    [No Abstract]   [Full Text] [Related]  

  • 6. [The efficacy of therapeutic lavage in the combined treatment of suppurative lung diseases].
    Nikolova M; Metev Kh; Gramatikov D
    Vutr Boles; 1989; 28(4):59-61. PubMed ID: 2596106
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of low frequency ultrasonic technology in preventing and treating purulent wounds of the lung and pleura].
    Pavlov IuV
    Khirurgiia (Mosk); 2002; (5):64-7. PubMed ID: 12077841
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of bacteriophage and antibiotics for prevention of acute postoperative empyema in chronic suppurative lung diseases].
    Ioseliani GD; Meladze GD; Chkhetiia NSh; Mebuke MG; Kiknadze NIa
    Grudn Khir; 1980; (6):63-7. PubMed ID: 6450089
    [No Abstract]   [Full Text] [Related]  

  • 9. [Change in patient reactivity in chronic nonspecific lung diseases under the influence of overall treatment at Yalta].
    Nikolaevskiĭ VV; Eremenko AE; Ivanov IK; Navrotskiĭ VV; Govorun MI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1979; (5):36-8. PubMed ID: 161439
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of different methods of pyopneumothorax treatment].
    Putov NV; Levashev IuN; Medvenskiĭ BV; Kokhanenko VV; Molodtsova VP
    Grudn Khir; 1987; (4):37-41. PubMed ID: 3623201
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of non-medicamentous methods of treatment with the aim to improve the immune status of patients with suppurative diseases and malignant neoformations of the lungs].
    Kogosova LS; Kogosov IuA; Kalabukha IA; Konovalov EP
    Probl Tuberk; 1993; (3):37-9. PubMed ID: 7984589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppurative lung disease: old problems revisited.
    Schachter EN
    Clin Chest Med; 1981 Jan; 2(1):41-9. PubMed ID: 7030597
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dynamics of the indices of natural resistance and of the response to staphylococcal alpha-toxin in acute suppurative lung diseases].
    Savitskaia KI; Solodilova OE; Dubova VG; Demokidova SM
    Grudn Khir; 1985; (6):68-71. PubMed ID: 4076827
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasmapheresis in the combination therapy of patients with pyogenic destructive diseases of the lungs and pleura].
    Alekseeva ME; Pavliutenkov MG; Daberkha M
    Grudn Khir; 1989; (1):59-62. PubMed ID: 2925111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pleural empyema and its treatment in acute purulent disease of the lung].
    Ostrovskiĭ VK
    Klin Khir (1962); 1984 Oct; (10):41-4. PubMed ID: 6513298
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pleural empyema after closed mitral commissurotomy].
    Korolev BA; Karov VV; Tevit BM; Chinenkova VN
    Vestn Khir Im I I Grek; 1983 Jul; 131(7):31-6. PubMed ID: 6623823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of purulent skin diseases with staphylococcal anatoxin].
    Lutowiecka-Wranicz A; Kulesza K; Czerneilewski J
    Przegl Dermatol; 1978; 65(5):583-8. PubMed ID: 725103
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of staphylococcal lung destruction in children].
    Marchuk IK
    Vestn Khir Im I I Grek; 1983 May; 130(5):105-7. PubMed ID: 6879923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperbaric oxygenation in the treatment of patients with acute purulent-destructive lung and pleural diseases].
    Lesnitskiĭ LS; Buravtsov VI
    Vestn Khir Im I I Grek; 1983 Jul; 131(7):36-42. PubMed ID: 6623824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological reactivity indices in suppurative lung diseases].
    Korol' OI; Nguyen NT
    Sov Med; 1981; (3):14-7. PubMed ID: 7244825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.